115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12935)
  10. Department of Pathology and Laboratory Medicine (12608)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimizing regulatory reviews for clinical protocols that use radiopharmaceuticals: Findings of the University of Pennsylvania Radiation Research Safety Committee
    Journal Article

    Rhodes, S. S.; Jesikiewicz, J. E.; Yegya-Raman, N.; Prasad, K.; Dreyfuss, A.; Mankoff, D. A.; Taunk, N. K.
    Health Physics (2024)

    Fulltext@MSK | Save
  • Outcomes of SMARCB1-deficient sinonasal carcinoma: Largest single-center cross-sectional study
    Journal Article

    Woods, R.; Scholfield, D.; Axiotakis, L.; Fitzgerald, C.; Adilbay, D.; Cracchiolo, J.; Patel, S.; Shah, J.; Dunn, L.; Pfister, D.; more...
    Head & Neck (2024)

    Fulltext@MSK | Save
  • Identifying somatic fingerprints of cancers defined by germline and environmental risk factors
    Journal Article

    Chakraborty, S.; Guan, Z.; Kostrzewa, C. E.; Shen, R.; Begg, C. B.
    Genetic Epidemiology (2024)

    Fulltext@MSK | Save
  • Association between objective measures of oral health and salivary gland irradiation with patient-reported outcomes following head and neck radiation therapy
    Journal Article

    Singh, A.; Long, S. M.; Tin, A. L.; Vickers, A. J.; Yom, S. K.; Lee, N. Y.; Huryn, J. M.; Cracchiolo, J. R.; Estilo, C. L.
    Head & Neck (2024)

    Fulltext@MSK | Save
  • The NEOLETRIB trial: Neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer
    Journal Article

    Fjermeros, K.; Ghannoum, S.; Geisler, S. B.; Bhargava, S.; Tahiri, A.; Klajic, J.; Lüders, T.; Fongård, M.; Nawaz, M. S.; Bosnjak-Olsen, T.; more...
    Future Oncology (2024)

    Fulltext@MSK | Save
  • MSH6-proficient crypt foci in MSH6 constitutional mismatch repair deficiency: Reversion of a frameshifted coding microsatellite to its wild-type sequence
    Journal Article

    Shia, J.; Sanchez-Vega, F.; Cho, S.; Chen, J. F.; Chen, C. T.; Bhanot, U.; Urganci, N.; Firat, C.; Ntiamoah, P.; Isidro, R. A.; more...
    Familial Cancer (2024)

    Fulltext@MSK | Save
  • Lenvatinib plus Pembrolizumab following immune checkpoint inhibitor treatment in patients with metastatic clear cell renal cell carcinoma: Results from study 111/KEYNOTE-146
    Research Letter

    Lee, C. H.; Yogesh Shah, A.; Rao, A.; Taylor, M. H.; Di Simone, C.; Hsieh, J. J.; Pinto, A.; Gironés Sarrió, R.; Lee Cohn, A.; Asim Bilen, M.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Realizing the scope of venous and arterial thrombosis in cyclin-dependent kinase 4/6 inhibitors in hormone positive breast cancer
    Editorial

    Wilkins, C. R.; Zwicker, J. I.
    European Journal of Internal Medicine (2024)

    Fulltext@MSK | Save
  • (89)Zr-immunoPET-guided selection of a CD33xIL15 fusion protein optimized for antitumor immune cell activation and in vivo tumour retention in acute myeloid leukaemia
    Journal Article

    Herrero Alvarez, N.; Molvi, Z.; Lupo, K.; Urraca, J.; Balderes, P.; Nyakatura, E. K.; Khan, A. G.; Viray, T.; Lewis, J. S.; O’Reilly, R. J.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Examination of the PET in vivo generator (134)Ce as a theranostic match for (225)Ac
    Journal Article

    Bauer, D.; De Gregorio, R.; Pratt, E. C.; Bell, A.; Michel, A.; Lewis, J. S.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save